Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Lupin

    Tag: lupin

    You Searched For "Lupin"
    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble

    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble

    Medical Dialogues Bureau7 Nov 2019 4:20 PM IST
    Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
    Lupin gets USFDA nod for generic version of Levoxyl tablets to treat hypothyroidism

    Lupin gets USFDA nod for generic version of Levoxyl tablets to treat hypothyroidism

    Medical Dialogues Bureau2 Nov 2019 10:00 AM IST
    The product is a generic version of King Pharmaceuticals Research and Development LLC's Levoxyl tablets in same strengths, Lupin said.New Delhi: Drug...
    Sreeji Gopinathan joins Lupin as Chief Information Officer

    Sreeji Gopinathan joins Lupin as Chief Information Officer

    Medical Dialogues Bureau3 Oct 2019 4:03 PM IST
    Mumbai, October 03, 2019: Pharma major Lupin Limited announced today the appointment of Sreeji Gopinathan as Chief Information Officer (CIO). He will...
    Lupin clears Japanese regulator PMDA inspection of Goa facility

    Lupin clears Japanese regulator PMDA inspection of Goa facility

    Farhat Nasim2 Oct 2019 9:50 AM IST
    The Pharmaceutical and Medical Devices Agency (PMDA), Japan, has completed the Good Manufacturing Practice inspection of the company's Goa facility...
    Lupin inks commercial pact with Creso Pharma for cannaQIX

    Lupin inks commercial pact with Creso Pharma for cannaQIX

    Medical Dialogues Bureau27 Aug 2019 10:00 AM IST
    As per the agreement, Creso has given Pharma Dynamics sole distribution rights of its products across South Africa, Namibia, Botswana, Zimbabwe,...
    Lupin, Glenmark recall hypertension, fungal infection drugs from US market

    Lupin, Glenmark recall hypertension, fungal infection drugs from US market

    Medical Dialogues Bureau26 Aug 2019 9:45 AM IST
    New Delhi: Pharma major Glenmark is recalling over 31,000 tubes of anti-fungal Clotrimazole and Betamethasone Dipropionate cream from the US market,...
    Lupin unveils generic version of Prozac tablets in US

    Lupin unveils generic version of Prozac tablets in US

    Medical Dialogues Bureau24 Aug 2019 9:45 AM IST
    Fluoxetine tablet is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, Lupin said.Mumba: Pharma major Lupin Limited...
    Lupin to sell Japanese injectables business to Abu-Dhabi based Neopharma group

    Lupin to sell Japanese injectables business to Abu-Dhabi based Neopharma group

    Medical Dialogues Bureau22 Aug 2019 9:50 AM IST
    "Under the terms of the agreement, Lupin has agreed to sell all the issued and outstanding share capital in Kyowa Criticare Co Ltd to neo-ALA Co Ltd....
    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Farhat Nasim18 Aug 2019 9:46 AM IST
    Hydrocortisone Valerate cream is a generic version of Sun Pharmaceutical Industries Ltd's Westcort cream in the same strength, Lupin added.New Delhi:...
    Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder

    Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder

    Medical Dialogues Bureau17 Aug 2019 9:45 AM IST
    The company has received approval for Fluoxetine Tablets from the US Food and Drug Administration(USFDA) to market its product which is a generic...
    Lupin gets EIR from USFDA for Oral Dosage facility in Aurangabad

    Lupin gets EIR from USFDA for Oral Dosage facility in Aurangabad

    Medical Dialogues Bureau5 Aug 2019 9:45 AM IST
    Lupin Ltd's Aurangabad facility is involved in the manufacture of Oral Solid Dosage, Oral Liquid and Powder for Oral Suspension products for the US...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok